Form 4 for AORT ARTIVION, INC.
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-06 · accession 0000784199-25-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-10 | 2025-03-06 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +19.2K | 117.5K | +20% | $0 | |
| 2025-03-10 | 2025-03-06 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $24.80 | -1,603 | 115.9K | -1% | -$39.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-06 | A | A | 19,240 | $0.00 | 117,483 | D | — | — | (F1) Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date. |
| 2 | Common | Common Stock | 2025-03-06 | S | D | 1,603 | $24.80 | 115,880 | D | — | — | (F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |